Could a simple drug switch protect the hearts of people with HIV?
NCT ID NCT04820933
Summary
This study looked at whether switching to a specific HIV medication called doravirine could be better for heart health compared to other common HIV drugs. It involved 26 adults with stable, treated HIV and high cholesterol. Researchers measured cholesterol function and markers linked to artery clogging to see if doravirine offered any protective benefits.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR RISK FACTOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Texas Southwestern
Dallas, Texas, 75219, United States
-
University of Texas Southwestern Medical Center
Dallas, Texas, 75219, United States
Conditions
Explore the condition pages connected to this study.